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Background: Zoonotic transmission of simian retroviruses in Central Africa is ongoing and can result in pandemic
human infection. While simian foamy virus (SFV) infection was reported in primate hunters in Cameroon and
Gabon, little is known about the distribution of SFV in Africa and whether human-to-human transmission and
disease occur. We screened 3,334 plasmas from persons living in rural villages in central Democratic Republic of
Congo (DRC) using SFV-specific EIA and Western blot (WB) tests. PCR amplification of SFV polymerase sequences
from DNA extracted from buffy coats was used to measure proviral loads. Phylogenetic analysis was used to define
the NHP species origin of SFV. Participants completed questionnaires to capture NHP exposure information.
Results: Sixteen (0.5%) samples were WB-positive; 12 of 16 were from women (75%, 95% confidence limits 47.6%,
92.7%). Sequence analysis detected SFV in three women originating from Angolan colobus or red-tailed monkeys;
both monkeys are hunted frequently in DRC. NHP exposure varied and infected women lived in distant villages
suggesting a wide and potentially diverse distribution of SFV infections across DRC. Plasmas from 22 contacts of 8
WB-positive participants were all WB negative suggesting no secondary viral transmission. Proviral loads in the three
women ranged from 14 – 1,755 copies/105 cells.
Conclusions: Our study documents SFV infection in rural DRC for the first time and identifies infections with novel
SFV variants from Colobus and red-tailed monkeys. Unlike previous studies, women were not at lower risk for SFV
infection in our population, providing opportunities for spread of SFV both horizontally and vertically. However,
limited testing of close contacts of WB-positive persons did not identify human-to-human transmission. Combined
with the broad behavioral risk and distribution of NHPs across DRC, our results suggest that SFV infection may have
a wider geographic distribution within DRC. These results also reinforce the potential for an increased SFV
prevalence throughout the forested regions of Africa where humans and simians co-exist. Our finding of endemic
foci of SFV infection in DRC will facilitate longitudinal studies to determine the potential for person-to-person
transmissibility and pathogenicity of these zoonotic retroviral infections.
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Human immunodeficiency viruses types 1 and 2 (HIV-1
and HIV-2, respectively) are recent examples of pandemic
retroviruses which originated from cross-species infections
from SIV-infected chimpanzees and gorillas, and sooty
mangabeys, respectively [1]. Human T-lymphotropic
viruses types 1, 2, and 3 (HTLV-1, -2, and −3) have
an ancient origin from simian T-lymphotropic virus
(STLV)-infected nonhuman primates (NHPs), but con-
temporaneous cross-species infections also occur [2]. The
historical zoonotic origin and pandemic potential of sim-
ian retroviruses raises public health concerns associated
with transmission of additional primate retroviruses to
humans.
Simian foamy viruses (SFVs) are ancient retroviruses
that have co-speciated with their NHP hosts for at least
30 million years [3]. Once acquired, SFV infections per-
sist but do not apparently cause disease in NHPs, though
systematic studies to evaluate disease associations are
lacking [4,5]. Various studies report that humans
exposed to NHPs show increased infection with simian
retroviruses, including SFV [6-12]. Although the total
number of human infections with SFV is not large,
populations at increased risk include zoo workers and
animal handlers in North America and Asia, and Africans
who hunt and butcher NHPs for bushmeat [6,7,11-13].
However, little is known about the geographic distribu-
tion of SFV beyond these populations. In addition, in-
formation on the health consequences of SFV infection
and its ability to spread from person to person is lim-
ited to data from cross-sectional studies and follow-up
of small numbers of infected people for only short peri-
ods [6]. One U.S. study following seven persons for a
median of 2 years following identification of SFV infec-
tion reported no evidence of secondary transmission or
disease associations [14].
Hunting and butchering of wild animals provides nutri-
tion and economic sustenance in many countries across
Africa. In Central and West Africa alone, approximately
3–5 tons of bushmeat are killed every year, of which al-
most 15% comes from NHPs (www.bushmeat.org). In
addition to hunting and consumption by locals, there is
also increasing international trade of bushmeat. These
socioeconomic and behavioral factors result in frequent
and possibly dangerous exposure to NHPs with concomi-
tant increased risk of infection with viral agents, including
simian retroviruses [15-19]. 75% of all emerging infectious
diseases are estimated to have a zoonotic origin, the ma-
jority (37%) being comprised of RNA viruses [15,16]. The
Democratic Republic of Congo (DRC) is an ideal setting
for studies on the cross-species transmission and emer-
gence of viruses considering the high levels of biodiversity
and wild NHPs, and the widespread exposure of rural vil-
lagers to primates by hunting and butchering. Forexample, recent studies have documented the presence of
novel SIVs and STLVs in bushmeat in DRC, and thus hun-
ters may be at increased risk for infection with these retro-
viruses [17]. In addition, high rates of HIV-1 genetic
variability have been reported in DRC, suggesting DRC as
the epicenter of the global HIV-1/M pandemic, and sup-
porting further the broad retroviral diversity in the region
[20-22]. Given the high viral diversity in DRC and the
emergence of other simian retroviruses in sub-Saharan
Africa, we screened a large population of rural DRC inha-
bitants for SFV infection. Detailed animal exposure and




Of 3,846 consenting participants living in the Kole
and Lomela health zones in 2007, demographic
information on age, gender, and village was collected
for nearly 97.5%. Villages in these two health dis-
tricts included Asenge, Olombo Munene, Kole
Yango, Ndjale, CERS Kole Yango, Tokondo, Djombe,
Loseke, Mamba Ewanga, Mamba Edinda, Mamba
Etende, Penashimba, Okoko, Penashimba, and
Bahamba (Figure 1). Of these participants, approxi-
mately 58% were female, 84% were younger than 45
years of age, and 27% reported daily visits to the for-
est (Table 1). The average age was 24.2 yrs., with a
median of 10 yrs. and range of 1 – 92 yrs. The age
distribution was younger for males (median 15 yrs.)
as compared to females (median 22 yrs.) (Wilcoxon
rank sum test, p<0.05)
Individuals were asked about their frequency of
entering forests, where animal diversity is greatest,
to estimate possible animal contact. Self-reported
encounters with NHP species included 1,781 (46%)
persons who ever encountered black mangabey
(Lophocebus aterrimus), 1,621 (42%) red-tailed gue-
non (Cercopithecus ascanius), 1,390 (36%) Tshuapa’s
red colobus (Piliocolobus tholloni), 1,273 (33%)
DeBrazza’s monkey (Cerco. neglectus), 1,265 (33%)
Angolan colobus (Colobus angolensis), 977 (25%)
Wolf ’s guenon (Cerco. wolfi), 697 (18%), agile
mangabey (Cercocebus chrysogaster), 498 (13%)
chimpanzee (Pan troglodytes), and 453 (12%) gorilla
(G. gorilla) (Table 1). 64.2% (2470/3846) of partici-
pants were not able to identify or remember one or
more of the simian species they came in contact
with. Exposure activities included 3,025 (79%) per-
sons who ate 1 or more species of NHP, 2,195 (57%)
cooked, 1,617 (42%) butchered or skinned, 247 (6%)
hunted, 93 (2%) brought animals dead from the for-
est, 33 (1%) ate uncooked, 30 (1%) played with, and
8 (<1%) were scratched or bitten by NHP (Table 2).
Figure 1 Location of human infections with simian foamy virus (SFV) in the Democratic Republic of Congo (DRC). Kole and Lomela
health zones are shown in boxes with the 14 rural villages within the Sankuru district in the east central forested region of DRC. A key of the sites
with different serologic and PCR evidence of SFV and those without evidence of SFV is provided. SFV prevalences are provided in parentheses
after village names. Tree cover is indicated by light green, woodland; dark green, forest; white, savanna.
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Plasma samples were available from 3,334 of the 3,846
participants (86.7%). 182/3,334 (5.4%) plasmas were re-
active in the Luminex EIA, and 54/3,334 (1.6%) were
also reactive in the standard EIA. 16/54 (29.6%) were
WB seropositive, showing reactivity to the SFV Gag
doublet proteins, giving an overall prevalence of 0.5%
(16/3,334), 95% confidence limits (CL) (0.3 – 0.8). The
WB assay has been previously shown to be 100% specific
and sensitive for confirming infection with variant SFV
[23]. Figure 2 is a representative of WB reactivity show-
ing both seropositive and seronegative specimens.PCR and phylogenetic analysis of new SFV sequences
Buffy coats were available for PCR from 14/16 WB-
positive persons. DNA integrity was confirmed in all 14
specimens by ß-actin PCR. DNA from only three persons
(ID#s 8223, 21044, and 40244), all women, was positive
for both SFV pol and LTR sequences (3/14, 21.4%). All
three PCR-positive individuals showed strong WBpositivity (Figure 2). DNA from the eleven other WB-
positive persons was all negative for both LTR and pol
sequences.
To determine the primate origin of SFV infection
in these three women, phylogenetic relationships were in-
ferred by implementation of neighbor-joining, maximum-
likelihood, and Bayesian methods using an alignment of
pol sequences from 173 NHPs and humans. All three
methods were highly congruent (data not shown). The
majority of SFV sequences available from Africa originate
from infected NHPs and humans residing in Cameroon;
however, these sequences are limited to certain sampled
species and do not include primates from DRC where our
study population is located. Thus, to achieve the highest
possible phylogenetic resolution we included in our ana-
lyses new SFV sequences from NHPs endemic to DRC
(Cercopithecus ascanius (red-tailed guenon, n=2), Ce. wol-
fii (Wolf ’s guenon, n=2), Colobus angolensis (Angolan
colobus, n=1)), and new SFV sequences from NHPs
hunted in Cameroon (Ce. pogonias (crested mona mon-
key, n=11), Ce. cephus (moustached guenon, n=5), Ce.
Table 1 Estimation of SFV prevalence by exposure to different simian species in DRC
Single variable models Multivariable model





Female 2238 58.2 12 0.54 2.2 (0.7, 6.7) 0.18 1.8 (0.6, 5.7) 0.31
Male 1608 41.8 4 0.25 ref3 ref
Age ≥ 45 635 16.5 5 0.79 2.3 (0.8, 6.7) 0.12 2.3 (0.8, 6.7) 0.13
Age < 45 3211 83.5 11 0.34 ref ref
Forest daily 1037 27.0 8 0.77 2.7 (1.0, 7.3) <0.05 3.0 (1.0, 8.7) <0.05
Forest <daily/never 2809 73.0 8 0.29 ref ref
Exposure1 to:
Black mangabey 1781 46.3 12 0.67 3.5 (1.1, 10.9) 0.03 3.5 (0.8, 14.3) 0.09
No Black mangabey 2065 53.7 4 0.19 ref ref
Red-tailed guenon 1621 42.1 6 0.37 0.8 (0.3, 2.3) 0.71 0.6 (0.2, 2.2) 0.43
No red-tailed guenon 2225 57.9 10 0.45 ref ref
DeBrazza’s monkey 1273 33.1 4 0.31 0.7 (0.2, 2.1) 0.49 0.6 (0.2, 2.6) 0.50
No DeBrazza’s monkey 2573 66.9 12 0.47 ref ref
Agile mangabey 697 18.1 4 0.57 1.5 (0.5, 4.7) 0.48 1.2 (0.2, 5.9) 0.84
No agile mangabey 3149 81.9 12 0.38 ref ref
Wolf’s guenon 977 25.4 4 0.41 1.0 (0.3, 3.1) 0.97 1.2 (0.3, 5.1) 0.78
No Wolf’s guenon 2869 74.6 12 0.42 ref ref
Chimpanzee 498 13.0 2 0.40 1.0 (0.2, 4.2) 0.96 0.5 (0.1, 3.2) 0.46
No Chimpanzee 3348 87.0 14 0.42 ref ref
Angolan colobus 1265 32.9 10 0.79 3.4 (1.2, 9.4) 0.02 4.0 (1.1, 14.7) 0.04
No Angolan colobus 2581 67.1 6 0.23 ref ref
Gorilla 453 11.8 3 0.66 1.7 (0.5, 6.1) 0.39 2.6 (0.5, 13.9) 0.27
No Gorilla 3393 88.2 13 0.38 ref ref
Tshuapa’s red colobus 1390 36.1 5 0.36 0.8 (0.3, 2.3) 0.68 0.2 (0.1, 1.0) >0.05
No red colobus 2456 63.9 11 0.45 ref ref
Unidentified NHP 2470 64.2 10 0.41 0.9 (0.3, 2.6) 0.89 0.7 (0.2, 2.2) 0.50
No Unidentified NHP 1376 35.8 6 0.44 ref ref
1Exposure behavior is discrete variable 0:6; primates with higher SFV prevalence (black mangabey, agile mangabey, Wolf’s guenon, Angolan colobus, gorilla) each
represent 1 species-exposure, whereas the other five species groups represent 1-species-exposure collectively.
2The odds ratio is interpreted as 1 greater species-exposure. The descriptive percentage and estimated prevalence rates reflect any exposure to 1 or more species.
3 ref, reference group in regression models.
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nosed guenon, n=6), Ce. diana (Diana monkey, n=3), Ce.
neglectus (DeBrazza monkey, n=8), and Colobus guereza
(Eastern black and white colobus or mantled guereza,
n= 4)). Ce. neglectus is present in both Cameroon and
DRC. We also included recently reported SFVs from
monkeys (Ce. solatus (sun-tailed guenon), Ce. cephus, Ce.
nictitans) in Gabon, and humans infected with monkey
SFVs from Gabon and Cameroon to increase phylogenetic
resolution of the SFV evolutionary histories [11,12]. SFVs
from different simian species clustered in statistically sup-
ported clades showing clear co-evolution of SFV with pri-
mate host (Figure 3a). Clades without DRC sequences
were collapsed for clarity. Sequences from two women(8223 and 21044) clustered clearly with SFV from Colobus
species with significant bootstrap and posterior probabil-
ities (Figure 3a). The pol sequence from person 40224
clustered strongly within the Cercopithecus/Chlorocebus
clade (Figure 3a).
When the subtrees containing the human DRC pol
sequences are expanded visually to show each individual
sequence, further resolution of the phylogenetic relation-
ships and confirmation of co-evolution at the species
level is revealed. Eleven distinct lineages within the
Cercopithecus/Chlorocebus clade were inferred of which
ten were Cercopithecus species-specific lineages, one
contained the Chlorocebus SFV (Figure 3b). The pol se-
quence from person 40224 clustered strongly with Ce.
Table 2 Estimation of SFV prevalence by type of activity with possible simian exposure in DRC
Single variable models Multivariable model









Female 2238 58.2 12 0.54 2.2 (0.7, 6.7) 0.18 3.3 (0.8, 12.9) 0.09
Male 1608 41.8 4 0.25 ref3 ref
Age ≥ 45 635 16.5 5 0.79 2.3 (0.8, 6.7) 0.12 1.9 (0.7, 5.7) 0.23
Age < 45 3211 83.5 11 0.34 ref ref
Forest daily 1037 27.0 8 0.77 2.7 (1.0, 7.3) <0.05 2.4(0.9, 6.9) 0.10
Forest < daily /never 2809 73.0 8 0.29 ref ref
Exposure method1:
Hunted 247 6.4 0 0 NA4 na
Never 3599 93.6 16 0.45
Brought animal dead
from forest5
93 2.4 1 1.08 2.1 (1.3, 3.4) 0.003 2.2 (1.3, 3.9) 0.007
Never 3753 97.6 15 0.40 ref ref
Butchered, Skinned 1617 42.0 9 0.56 1.4 (1.1, 1.8) 0.02 1.4 (0.9, 2.1) 0.13
Never 2229 58.0 7 0.31 ref ref
Cooked 2195 57.1 10 0.46 1.2 (0.9, 1.6) 0.17 0.8 (0.5, 1.3) 0.36
Never 1651 42.9 6 0.36 ref ref
Ate 3025 78.6 12 0.40 1.2 (0.9, 1.5) 0.26 1.1 (0.7, 1.6) 0.82
Never 821 21.4 4 0.49 ref ref
Ate uncooked 33 0.9 0 0 NA NA
Never 3813 99.1 16 0.42
Played with 30 0.8 0 0 NA NA
Never 3816 99.2 16 0.42
Scratched or bitten by 8 0.2 1 12.50 2.8 (0.9, 9.0) 0.08 3.9 (1.2, 13.3) 0.03
Never 3838 99.8 15 0.39 ref ref
1Exposure behavior is discrete variable 0:6; primates with higher SFV prevalence (black mangabey, agile mangabey, Wolf’s guenon, Angolan colobus, gorilla) each
represent 1 species-exposure, whereas the other five species groups represent 1-species-exposure collectively.
2The odds ratio is interpreted as 1 greater species-exposure. The descriptive percentage and estimated prevalence rates reflect any exposure to 1 or more species.
3 ref, reference group in regression models.
4 NA, not applicable. Exposure variables were not included in regression models if there were no cases among persons identified as having the exposure.
5Brought dead animal excludes hunting NHPs.
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21044 clustered unambiguously with Co. angolensis with
significant statistical support (Figure 3c). Both Ce.
ascanius and Co. angolensis are endemic to DRC. The
sequences from persons 8223 and 21044 shared 98.4%
identity and were 96.7 – 97.4% identical to the Co.
angolensis SFV pol sequence. The two Ce. ascanius
sequences (PS217 and PS107) shared 99.3% identity, while
the 40224 pol sequence shared about 95% nucleotide iden-
tity with the Ce. ascanius sequences.
Given the high levels of phylogenetic resolution at
the species level in the Cercopithecus clade, we also
included in our analyses pol sequences from infected
humans in Cameroon and Gabon to explore further the
species origin of these SFVs that were previously in-
ferred to originate from cross-species infection from
Cercopithecus species [11,12,24,25]. Seven sequencesfrom infected Cameroonian hunters (AG16, Ako254,
Bad50, Bad179, Bad202, Bad436, Cam2467LE) were pre-
viously thought to originate from Ce. neglectus by clus-
tering with SFV from captive animals (Cne(Pollux) and
Cne(Elise)). However, we show that SFV in Cameroo-
nians AG16, Ako254, Cam2467LE are within the diver-
sity of SFV from Ce. nictitans from Cameroon with
strong statistical support (Figure 3b). These results are
in agreement with recent reports that investigated the
origin of SFV infection in a hunter from Gabon and
Cameroon [11,12]. Four other hunter SFVs (Bad50,
Bad179, Bad202, and Bad436) clustered strongly within
the Cameroonian Ce. cephus clade (Figure 3b) and not Ce.
neglectus as described previously [11]. Only SFV from an
infected hunter in Gabon (H14GabMM) showed phylo-
genetic relatedness to SFV from Ce. neglectus from Kenya




























































Figure 2 Identification of human infection with simian foamy virus (SFV) in the Democratic Republic of Congo. Detection of plasma
antibodies to SFV from chimp (SFVcpz) and monkey (SFVagm) using a combined antigen Western blot assay. Upper panel shows reactivity to the
combined antigen, lower panel shows reactivity to crude cell lysate antigens from uninfected canine thymocytes (Cf2Th). Seroreactivity was
defined as those specimens with reactivity specific to the diagnostic Gag doublet proteins in the combined viral antigens. Lanes 1 and 2 show
positive plasma controls from an SFV-infected chimpanzee and monkey, respectively. Lane 3 is a pedigreed negative human plasma control.
Study participant plasma samples that were also PCR-positive are marked with an asterisk.
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that showed it clustered with C. nictitans from Gabon.
SFVs from the two captive (Pollux and Elise) and one wild
Ce. neglectus from Gabon (CneGab01WD) all fell within
the diversity of the Ce. pogonias SFV (Figure 3b), and not
Ce. neglectus as originally inferred, indicating probable
cross-species transmission with this virus while in captiv-
ity and in the wild. The two captive Ce. neglectus were in a
mixed monkey coral, including Ce. pogonias, supporting
this possibility, while the provenance of the wild DeBrazza
was not reported [12].
Phylogenetic analysis of the LTR sequences was
not performed since only a small number of SFV
sequences from a limited number of simian species
are available at GenBank. In addition, the LTR xre-
gion is highly divergent, and thus alignments with
all available SFVs do not contain enough phylogen-
etic signal to accurately resolve the genetic relation-
ships. LTR sequences from persons 8223 and 21044
were 96.6% identical and shared 70.8 – 73.4%
nucleotide identity with LTR sequences from Co.
guereza (Cgu910916) and Procolobus r. tephrosceles
(KRC6, KRC67, KRC70, and KRC72) [26]. The 40224
LTR sequence was nearly equidistant to those from
various Cercopithecus SFVs, including Ce. albogularis
(Cal(Syk119), Ce. neglectus (CNE01), Ce. mona
(Cmo104), and the Cameroonian hunter infected
with a Ce. nictitans SFV (Cam2467LE) [25], sharing
between 80.1 – 89.1% nucleotide identity.
All new pol and LTR SFV sequences generated in the
current study have been deposited in GenBank with the
following accession numbers JX157538 – JX157580.Proviral loads in SFV-infected women
The new qPCR assay was found to be 100% specific by not
detecting SFV in 76 blood donor and 10 commercially
available human genomic DNAs all previously shown to be
negative using nested generic pol PCR [23]. We also
observed excellent sensitivity and broad detection of SFV
variants from monkeys and apes. The assay detected 1–5
copies of SFVcpz(strains 199917 and X174), SFV1(mac),
SFV3(agm), SFV10(bab), SFV11(ora), SFVmnd(1465MV),
SFVcmo(2719YI), SFVdeb(2467LE), and SFVgor(1083MO).
One woman (DRC21044) infected with Angolan colobus
SFV had 1,755 copies/105 cells, while proviral loads in the
other two women (DRC8223 and DRC40224) were much
lower (319 and 14 copies/105 cells, respectively). DNA from
the 11 other WB-positive persons tested below the limit of
detection in the qPCR assay.
Epidemiology
Demographic, exposure, and infection data of the SFV
seropositive persons are summarized in Table 3. The
ages of the 16 WB-positive persons ranged from 11 to
62 yrs. old (mean 32.7 yrs., median 27 yrs.); 12/16 (75%)
were female. SFV infection was observed in six of the 14
villages in the Kole and Lomela health zones with preva-
lences ranging from 0.2 – 1.3% (Figure 1). Two WB-
positive individuals did not report contact with NHPs
though they reported entering the forests at least four
times per month. Thirteen persons reported NHP expos-
ure, including picking up carcasses for consumption,
butchering and preparing for consumption, and eating.
One person (23542) did not complete the questionnaire
































































Figure 3 Inference of the evolutionary history of human infections with simian foamy virus (SFV). a. Circular maximum clade credibility
(CMCC) tree of 173 SFV polymerase (pol) sequences generated by Bayesian analysis using the programs BEAST [44] and FigTree (http://tree.bio.ed.
ac.uk/software/figtree/) and a relaxed molecular clock. Trees were midpoint rooted. Final alignment length was 391-bp. Similar trees were inferred
by maximum likelihood and neighbor-joining methods (data not shown). Inferred histories of the new human SFVs from DRC are shown with
arrows. Major clades without human sequences from DRC are collapsed. b. Subtree of CMCC tree showing detailed phylogenetic relationships of
human infections in the Cercopithecus and Chlorocebus clade. Dots and triangles indicate SFV sequences from nonhuman primates (NHPs) from
Cameroon and Gabon, respectively. New SFV sequences from NHPs in DRC are in italics. SFV sequences identified in humans are in bold and
country of origin is abbreviated (CAM, Cameroon; Gab, Gabon, DRC, Democratic Republic of Congo). Code for NHP species is first letter of genus
followed by first two letters of species with animal name or code in parentheses, except for Ptt (Pan troglodytes troglodytes). c. Subtree of CMCC
tree showing detailed phylogenetic relationships of human infection in the Colobus clade. New SFV sequence from C. angolensis from DRC is in
italics. Dots indicate new SFV sequences from NHPs from Cameroon. SFV sequences identified in humans from DRC are in boxes. Code for NHP
species is first letter of genus followed by first two letters of species with animal name or code in parentheses. Bootstrap support for NJ and ML
analyses and posterior probabilities are given at selected nodes in that order. Reference sequences were obtained from GenBank.
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and 50 years of age from Tokondo, Asenge, and Djombe,
respectively. Asenge and Tokondo are about 200 km
apart and represent the greatest distance between vil-
lages in the study (Figure 1). Person 8223 reported ex-
posure to Angolan colobus and black mangabey and is
infected with Angolan colobus SFV (Table 3). Person
21044 reported exposure to red-tailed guenon but isinfected with Angolan colobus SFV. Person 40224
reported no primate exposure but is infected with red-
tailed guenon SFV and reported entering the forest at
least four times per month (Table 3). Neither PCR posi-
tive woman who reported monkey exposure reported
being bitten by monkeys, which contrasts with the
increased level of bite wounds associated with SFV in-
fection reported in other studies in Africa [11,24]. Buffy
Table 3 Identification of frequent simian foamy virus (SFV) infection in rural DRC
ID Sex, Age Village Forest frequency NHP exposure1 SFV WB SFV pol PCR2 sequence
6753 F,12 Tokondo Never B, PE, E Positive Negative
8223 F, 23 Tokondo Everyday B, PE, E Positive Co. angolensis
14092 M, 13 Loseke 2-4 times/month PDE, B Positive Negative
21044 F, 57 Asenge Everyday PE, E Positive Co. angolensis
22492 F, 62 Olombo Munene >4 times/month B, PE, E, S, BN Positive NA
23542 M, 32 Asenge 2-4 times/month NA Positive Negative
30015 F, 62 Asenge Everyday B, PE, E Positive Negative
32863 F, 36 Asenge Everyday B, PE, E Positive NA
33740 F, 13 Asenge >4 times/month B, PE, E Positive Negative
35222 F, 18 CERS Kole Yango Everyday None reported Positive Negative
38662 F, 21 CERS Kole Yango >4 times/month B, PE, E Positive Negative
39443 F, 11 CERS Kole Yango Never E Positive Negative
39911 M, 59 Djombe Everyday B, PE, E Positive Negative
40224 F, 50 Djombe >4 times/month None reported Positive Ce. ascanius
41274 F, 25 CERS Kole Yango Everyday PE, E Positive Negative
42652 M, 29 Kole Yango >4 times/month E Positive Negative
1.NHP, nonhuman primate; PDE, pick up dead monkey to eat; B, butcher monkey; PE, prepare monkey to eat; E, eat monkey; S, scratched by monkey; BN, bitten
by monkey.
2.pol, polymerase; when PCR is positive monkey origin of infection is provided.
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woman (22492) and a 36 year old female (32863) for
PCR testing.
Plasma specimens were available for WB testing from
close contacts, defined as living in the same household,
of person 21044 and from those of seven other WB-
positive participants to evaluate person-to-person trans-
mission of SFV (Table 4). The teenage daughter and son
of person 21044 were both negative for antibodies to
SFV. All 20 contacts of the seven other WB-positive par-
ticipants were also WB negative, including four spouses,
two parents, 5 offspring, and 6 siblings (Table 4).
We analyzed the questionnaire data to determine if ex-
posure to specific primates or activities increased the
risk of SFV WB positivity. Using the multiply imputed
complete datasets the estimated SFV prevalence was
0.42% (95% CL 0.24 - 0.67), which is slightly lower than
the actual prevalence of 0.5% in the 3,334 participants
for whom plasma was available for testing. Estimated
SFV prevalence was significantly elevated for persons
who frequented the forest daily (0.77%, 95% CL 0.33 -
1.51), who were exposed to black mangabey (0.67%, 95%
CL 0.35 - 1.17) or Angolan colobus (0.79%, 95% CL 0.38
- 1.45), who brought dead NHPs home from the forest
(1.08%, 95% CL 0.03 - 5.85), who butchered or skinned
NHPs (0.56%, 95% CL 0.25 - 1.05), or who were
scratched or bitten by NHPs (12.50%, 95% CL 0.32 -
52.65) (Table 1). These same exposures were significant
(p<0.05) in the single-variable logistic regression models,
with odds ratios (OR) of 1.4 and 2.1 (95% CL 1.1, 1.8and 1.3, 3.4, respectively) for each additional species-
exposure due to butchering and skinning NHP or bring-
ing dead animals from the forest, respectively, and odds
ratios of 3.4 and 3.5 (95% CL 1.2, 9.4 and 1.1, 10.9, re-
spectively) for any type of exposure to Angolan colobus
and black mangabey, respectively (Table 1). Because few
persons were bitten or scratched by NHP, the association
of this exposure with SFV prevalence was not statisti-
cally significant in the single-variable model, but this ac-
tivity was independently associated with higher SFV
prevalence in the multivariable model (OR 3.9, 95% CL
1.2 - 13.3). Other independent risk factors for SFV infec-
tion that were significant (<0.05) in the multivariable
model include exposure to Angolan colobus (OR 4.0,
95% CL 1.1 - 14.7) and bringing dead NHPs from the
forest (OR 2.2, 95% CL 1.3 - 3.9). Interestingly, making
daily trips into the forest was significantly associated
with risk for SFV infection as evidenced by the model
that controlled for NHP species (OR 3.0, 95% CL 1.0 -
8.7) (Table 1), but was no longer significant and had
reduced strength of association to SFV infection based
upon results from the model that included explanatory
variables for activities while in the forest (Table 2).
Discussion
Human infection with SFV was first identified in 1971 in
a Kenyan with nasopharyngeal carcinoma and since then
has been found in other populations around the world
who are exposed to NHPs, but without overt evidence of
disease [6]. To date about 136 persons have been
Table 4 No evidence of transmission of simian foamy virus (SFV) to close contacts of Western blot-positive persons
from the Democratic Republic of Congo
ID of seroreactive person Role in family Sex, Age ID of Relative Relationship to
seroreactive person
Sex, Age1 SFV EIA Luminex
210442 Head3 F, 57 29573 Daughter F, 15 Negative
29584 Son M, 12 Negative
23542 Head M, 32 23273 Wife F, 41 Negative
27075 Daughter F, 5 Negative
30015 Wife of head (not primary) F, 62 20274 Daughter F, 10 Negative
18233 Son M, 8 Negative
20335 2nd wife of head (not primary) F, 40 Negative
30004 Grandson of head M, 4 Negative
32863 Wife of head (primary) F, 36 32826 Son M, 8 Negative
33574 Daughter F, 10 Negative
34090 Daughter F, 6 Negative
33740 Daughter of head F, 13 32992 Wife of head F, 21 Negative
33762 Maternal aunt F, 23 Negative
33773 Father (head) M, 29 Negative
33784 Brother M, 7 Negative
33751 Uncle M, 21 Negative
35222 Daughter of head F, 18 35200 Father (head) M, 79 Negative
35211 Brother M, 6 Negative
35233 Brother M, 4.9 Negative
39443 Daughter of head F, 11 39421 Wife (not primary) F, 28 Negative
39432 Sister F, 16 Negative
39454 Sister F, 9 Negative
41274 Daughter of head F, 25 41285 Brother M, 24 Negative
1.Age in years.
2.Infected with SFV from Ce. ascanius (red-tailed guenon).
3.Head of household.
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four continents [6,11,12]. However, given the high preva-
lence of SFV in NHPs, the frequent exposure to NHPs
by persons who handle and consume NHPs, and the in-
creasing demand for bushmeat in Africa and globally,
models have predicted an even higher potential preva-
lence of SFV among humans [27]. Thus, to better assess
the public health implications of this novel human infec-
tion requires a more comprehensive understanding of
the epidemiology of SFV, including its geographical dis-
tribution, the evolutionary history of SFV in humans
and NHPs, determination of exposure risks, and a thor-
ough evaluation of secondary transmissibility and patho-
genicity of SFV in humans and NHPs.
DRC is an ideal location for increasing our knowledge
about emerging zoonotic infections since the majority of
the population lives in rural forested regions where NHP
density is greatest and who rely on bushmeat as a major
food and income source. Our finding of 16 SFV WB-
positive persons increases the total number of knownglobal infections to 153, with 17 in DRC, including one
woman who was previously found co-infected with HIV-1
and SFV in Kinshasa in 1985 [28]. These discoveries sup-
port the presence of SFV in humans in DRC for at least
two decades in both urban and rural settings. Given the
wide exposure to NHPs across DRC, our results suggest
that SFV infection may have a wider geographic distribu-
tion within DRC. Our results also reinforce the potential
for an increased SFV prevalence throughout the forested
regions of Africa where humans and simians co-exist.
Also, since SIV and STLV are highly prevalent in NHPs,
rural populations in close contact with NHPs may also be
at increased risk for co-infection with other simian retro-
viruses. Indeed, novel STLVs have been reported recently
in NHP hunter cohorts from Cameroon who were also
infected with SFV [8,29-31] suggesting that zoonotic
transmission of simian retroviruses is an ongoing
phenomenon. The continued clearing of forests combined
with economic declines in DRC resulting from recurrent
civil war forces residents to rely on alternative protein
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tential for increased exposure to simian retroviruses. Our
study documents an increased risk of SFV infection in
persons preparing NHPs for consumption, or getting bit-
ten and scratched by NHPs, or bringing dead NHPs from
the forest, though there was insufficient evidence to con-
clude elevated risk for SFV infection from hunting NHPs
after controlling for age and gender in the multivariate
models. However, we also found that low exposure activ-
ities, such as entrance into the forest daily, placed persons
at elevated risk for SFV infection. SFV has been found in
feces and urine and could be sources of infection in these
frequent forest visits [14,32]. Nonetheless, direct evidence
for such transmissions is not available. Human infection
with SFV has been identified in animal handlers who did
not report known mucocutaneous exposures to infected
animals suggesting that less intimate contact with body
fluids may possibly place persons at risk for infection [33].
While handling and processing of dead NHPs can lead to
exposure to SFV and other simian retroviruses, contact
with dead primates and other mammals in Africa has also
resulted in fatal exposure and spread of the Ebola virus
that causes hemorrhagic fever, raising public health con-
cerns for this practice. Thus, increased public awareness is
needed in these communities, including educational mes-
sages advising caution in primate hunting and handling,
and forest safety, to prevent cross-species viral infections.
Curiously, SFV prevalence in our study population did
not differ by gender. We have previously identified SFV
antibodies in a female sex worker in DRC [28]. These
results contrast with all other African studies where
male hunters were more likely to be infected via more
severe NHP contact, such as bite wounds [6,11,12]. Men
who work with captive animals are also more frequently
infected with SFV than women [6]. However, the higher
prevalence seen in men in Cameroon and Gabon may
have been biased by the recruitment of mostly hunters,
which traditionally is a male activity in those countries.
Data from our questionnaire support the fact that men
are the primary hunters in DRC with women more com-
monly performing food preparation tasks. Although the
number of severe cutaneous exposures in our study was
low, this exposure increased the risk for SFV infection.
Women processed bushmeat for consumption more fre-
quently than men in our study possibly resulting in more
mucocutaneous exposures. The reasons for our inability
to detect SFV sequences in eleven WB-positive persons,
including seven females and four males, are unclear
and may be due to infection with highly divergent SFVs
not detected with the current assays, low proviral loads,
abortive infections, nonspecific seroreactivity, or other
reasons. While similar results have been previously
reported in other African countries which also used very
generic PCR assays [11,12,24,25], the WB assay used inthe current study has been shown to be highly sensitive
and specific for detecting SFV infection [23]. Testing of
longitudinal specimens may be necessary to investigate
persistent SFV infection in these WB-positive and PCR-
negative persons.
While the major route for SFV transmission in NHPs
appears to be via saliva from bites by juvenile and adult
animals [5,6], little is known about the transmission of
SFV from mother-to-child. Nonetheless, vertical transmis-
sion should be considered, including during birth or
through breast feeding since evidence for vertical trans-
mission from an SFV-infected chimpanzee to a female off-
spring in captivity has been reported [33]. The youngest
SFV-positive person in our study was an 11-year old girl
who reported eating NHPs but not going into the forest,
and her mother was not a study participant. Eating NHPs
was not associated with WB-positivity in our study, thus,
we are unable to assess the origin of her infection. Our
study was primarily designed to enroll participants from
each village in a serosurvey and thus included household
contacts of persons found to be infected in each village,
which facilitated our investigation of secondary SFV trans-
mission. While we were unable to identify any serological
evidence of SFV transmission to small numbers of close
contacts tested in our study, the duration of the spousal
relationships in this polygamous culture, the usage of bar-
rier contraception that might prevent sexual transmission,
and duration of breast feeding were not recorded to fully
assess the effect of these factors on transmission. Proviral
loads in one woman were high and were 12 times those
reported in hunters from Cameroon, which ranged from
undetectable to 145 copies/105 cells [11]. The increased
viral loads seen in this woman may result in increased
transmissibility and/or pathogenicity of her infection but
longitudinal studies are required to investigate this hy-
pothesis. Although both of her teenage children were
serologically negative for SFV, it is not known when the
mother became infected. The wife of an SFV-infected
hunter in Cameroon was reported to be persistently WB-
positive but PCR-negative, suggestive of a possible case of
person-to-person transmission [11]. However, information
regarding her primate exposure was not disclosed to ex-
clude a zoonotic origin of the infection. Likewise, we iden-
tified an SFV-infected woman in the current study who
did not report any specific primate exposures also suggest-
ive of a human-to-human transmission, but whose con-
tacts were not available for testing to evaluate this
possibility. Alternatively, self-reporting and recall bias
could account for these results. Data on SFV shedding in
vaginal secretions, breast milk, or semen from infected
persons may provide important information on mother-
to-child or sexual transmission.
The lower SFV prevalence seen in DRC, and the 1%
reported in our study in Cameroon, contrasts with the
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Gabon in populations enriched for cross-species infections
by targeting persons with severe simian exposures, includ-
ing bites and wounds. The primary focus of our study was
to investigate the seroprevalence of monkeypox infection
in selected health zones in the Sankuru district and
included persons with or without any NHP and animal ex-
posure. Our study population reported few severe expo-
sures and thus the lower SFV prevalence (0.5%) seen in
our study most likely better represents infection preva-
lence in the general population compared to the higher
rate seen in highly exposed persons in previous studies
[11,12,24]. The lower SFV prevalence may also result from
almost a third of our population being less than 10 years
old, and younger children may have less overall NHP ex-
posure. Interestingly, the SFV prevalence was about half
that seen for HIV-1 (1.2%) in Central-south DRC reported
from the 2007 Demographic and Health Survey (DHS)
(http://www.measuredhs.com). Unlike HIV-1, SFV is not
screened for at blood banks and thus transmission via
transfusion of contaminated blood products requires more
thorough investigation. Blood-borne transmission has
been reported in macaque models demonstrating that
transmission via this route is possible [34,35].
Limited information prevents us from drawing strong
conclusions on the disease potential of SFV infection [6].
Clinical information was not collected during our cross-
sectional study so we were unable to ascertain possible
diseases in SFV-infected persons. Longitudinal follow-up
studies of infected persons and close contacts are required
to better understand the epidemiology of these novel
human infections, and to evaluate the role of SFV in dis-
ease and transmissibility. In addition, testing of persons
with various diseases like cancer and neurological disor-
ders in endemic regions would be beneficial to ascertain
possible disease associations. Our data may also be limited
by recall bias or the possible inaccurate reporting of NHP
species that participants remembered exposure to. Al-
though NHP species were chosen by participants using
NHP pictures with their common names it may be diffi-
cult to distinguish between some monkey species.
Previously, we have shown that SFVs have co-evolved
with their primate hosts over millions of years such that
phylogenetic analysis of simian and human SFV
sequences together can be used to accurately identify
the species origin of human infections [3,6]. Detailed
phylogenetic analysis using the largest dataset of SFV
pol sequences assembled to date, including new SFVs
endemic to NHPs from Cameroon and DRC, allowed ex-
ceptional resolution of the primate origin of human
infections in DRC and also of those reported in Cameroon
and Gabon [11,12]. We identified infection in three
women in DRC with novel SFVs not seen before in
humans, including SFV from red-tailed guenons (Ce.ascanius) and Angolan colobus (Co. angolensis), both of
which inhabit only forests in DRC and are frequently
hunted. Statistical analysis inferred that SFV prevalence
was elevated in persons reporting exposure to Angolan
colobus. In addition, we show that six hunters from
Cameroon previously suspected of being infected with
SFV from Debrazza guenons (Ce. neglectus) are actually
infected with SFV from greater spot-nosed (Ce. nicti-
tans) or moustached (Ce. cephus) monkeys, which are
hunted more frequently than Debrazza monkeys in
Cameroon [36]. Combined with SFV infection originat-
ing from red-tailed guenons, mona monkey (Ce. mona),
and Debrazzas in persons from DRC, Cameroon and/or
Gabon, humans are susceptible to SFV variants from
five different Cercopithecus monkeys. Colobus, gorilla,
chimpanzee, mandrill, baboon, and macaque SFVs can
also infect humans from both captive and/or wild ani-
mals [6]. This high level of SFV diversity that has
crossed into humans demonstrates a broad susceptibility
to SFV infection, which contrasts with the more restricted
susceptibility to SIV, since of the 45 known SIV variants
only three (SIVcpz, SIVgor, SIVsmm) have crossed into
humans at varying levels, two of which spread globally as
HIV-1 (SIVcpz) and HIV-2 (SIVsmm). It is uncertain if
any of the SFV variants identified so far will spread in
humans and become a bona fide human virus.
Conclusions
We report the results of a thorough epidemiologic inves-
tigation of SFV infection in DRC. Using a combined
serologic and molecular approach we identify human in-
fection with new SFVs from Angolan colobus and red-
tailed monkeys, two NHP species hunted frequently in
DRC. We also demonstrate that detailed phylogenetic
analysis of SFVs found in humans, combined with those
from simians in the same ecological niche, are needed to
accurately define the zoonotic origin of human infec-
tions. Our findings suggest that SFV is widely prevalent
across Africa in men and women exposed to NHPs and
emphasize the importance of additional studies to deter-
mine human-to-human transmissibility and pathogen-
icity. The identification of endemic foci of SFV infection
in women in three locations within central DRC will
help facilitate these longitudinal studies.
Methods
Study population and specimen preparation
The population comprised 3,846 persons residing in 14
rural villages in the Sankuru district in the Kasai Orien-
tal province in central DRC as part of a study on human
monkeypox and other viral diseases (Figure 1). The local
population includes subsistence farmers and hunters
obtaining most of their protein from hunted wildlife, in-
cluding monkeys, rodents, and ungulates. The most
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ance, while the least nutritious parts are kept for per-
sonal consumption. The UCLA Institutional Review
Board approved collection, storage, and future testing of
blood samples collected in 2007 from all consenting
study participants. Blood specimens were processed for
plasma and buffy coats in DRC, aliquoted and stored at
−80°C. A non-research determination was approved for
testing of anonymized samples at CDC for retroviruses.
Study questionnaires were completed to obtain demo-
graphic and animal contact information.
NHP specimens and preparation
Dried blood spots (DBS) were collected from captive and
hunted NHPs endemic to Cameroon and DRC, as previ-
ously described, with approvals from local zoos, and For-
estry and Wildlife Ministries [37,38]. DNA was extracted
from DBS using the Nuclisens (Biomeriuex) or Qiagen
blood kits for the DRC and Cameroon samples, respect-
ively, as described in detail elsewhere [37,39]. DNA integ-
rity was confirmed by PCR of ß-actin sequences [37].
Species identification was recorded in the field and con-
firmed on all NHP samples from DRC by amplifying 12S
rRNA sequences [40] or by phylogenetic analysis of SFV
sequences as previously described [6].
Simian foamy virus serology
Plasmas were first screened for SFV antibodies using a
newly developed, high throughput, Luminex-based EIA
assay. All seroreactive samples were then tested using a
standard EIA format. Recombinant (rec) SFV proteins
for the two EIA-based assays were prepared from
complete SFV gag genes that were PCR-amplified from
Cf2Th cultures infected with either African green mon-
key (SFVHu1) or chimpanzee (SFVHu6) SFVs previously
isolated from humans [33]. Inclusion of proteins from
both SFVHu1 and SFVHu6 in the serological assays
ensures detection of broad seroreactivity to monkey and
ape SFV, respectively [23]. Details of the Luminex-based
EIA procedure have been reported recently [38]. Plasma
was diluted 1:200 and incubated with the recGag pro-
teins coupled to Luminex beads in microtiter plates. The
BioPlex-200 (BioRad, Marnes La coquette, France) and
BioPlex Software Manager v5.0 were used to analyze the
reacted and washed bead sets. At least 100 events were
read with results expressed as median fluorescence inten-
sity (MFI)/100 beads. The cut-off value was calculated for
each recGag protein as the mean MFI for all antibody
negative reference sera plus 5 standard deviations and was
set at 200 MFI. The sensitivity of the assay, evaluated on a
reference panel of specimens from SFV WB-positive
humans (n=47) and NHP species (n=13) was 85%. Assay
specificity, assessed on a reference panel of 90 SFV WB-
negative human samples was 97.2%.Standard SFV EIA testing was performed with previ-
ously described methods using a 1:100 plasma dilution
[25]. Each test run included SFVcpz and SFVagm-
positive control plasmas and two pedigreed SFV-
negative human control plasmas for assay validation.
The EIA is 96% sensitive and 97% specific using human
and simian plasma from PCR-positive (n=101) and PCR-
negative (n-=605) individuals (data not shown). Seror-
eactivity was defined as those samples with an optical
density (OD) greater than the cutoff of the mean OD
values of the two negative controls plus 0.312, which is
three standard deviations of the mean of the observed
seroreactivity of the PCR-negative samples.
Specimens dually reactive in the Luminex and stand-
ard EIA were tested using a WB assay to confirm the
observed seroreactivity as described previously [23].
Samples reactive to p68 and p72 or p70 and p74 Gag
doublet proteins, while showing an absence of a similar
reactivity to the uninfected CF2Th control antigen, were
considered WB-positive and infected with SFV.
SFV PCR, sequence analysis, and proviral loads
DNA was extracted from buffy coats available from per-
sons with seropositive WB results using the Flexigene
DNA extraction kit (Qiagen) and quantified using a
Nanodrop instrument. DNA integrity was verified using
β-actin PCR as described elsewhere [41,42]. One ug of
DNA was input for a generic SFV nested PCR assay to
detect 465-bp polymerase (pol) and 300-330-bp long ter-
minal repeat (LTR) sequences as described elsewhere
[23,25]. The pol and LTR primers can detect highly di-
vergent SFV from a variety of primate species [6,23].
DNA from tissue culture cells infected with a macaque
SFV (SFVmac) was used as a positive control for both
PCRs. SFV pol sequences were aligned using Clustal W
along with reference and new sequences representative
of a number of NHP species, including those endemic to
DRC, Cameroon, and Gabon. Phylogenies were con-
structed using neighbor-joining (NJ), maximum likeli-
hood (ML), and Bayesian inference as described
previously [3,6,26]. Briefly, NJ and ML methods were
implemented using the program MEGA v5.0 [43]. The
HKY+G (0.8518) model of nucleotide substitution was
inferred using the ML method with goodness of fit mea-
sured by the Bayesian information criterion in MEGA5
for the NJ and ML methods. 1,000 bootstrap replicates
were used to determine the robustness of the NJ and
ML tree topologies. Bayesian trees were inferred using
the program BEAST v1.6.2 and the HKY+G model with
an uncorrelated lognormal relaxed-clock model of nucleo-
tide substitution and a Yule speciation tree prior and 40
million Markov chain Monte Carlo (MCMC) chains [44].
Convergence of the chain sampling was checked in the
program Tracer for effective sample sizes (ESS) > 500.
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with the maximum product of the posterior clade prob-
abilities (maximum clade credibility tree) was chosen from
the posterior distribution of 10,001 sampled trees after
burning in the first 1,000 sampled trees with the program
TreeAnnotator version 1.6.2. Trees were viewed in FigTree
version 1.3.1 and in the MEGA5 tree editor.
Limited information exists regarding viral loads in SFV-
infected humans and NHPs [11], which has been asso-
ciated with increased pathogenicity and transmissibility of
other human retroviruses. To investigate proviral loads in
PCR-positive persons we developed a generic quantitative




AC3’BHQ1) and SIP5RON (FAM5’CTTTGRGGRTGRTA
AGGAGTACTGWATTCC3’BHQ1). One μg DNA, equiva-
lent to about 105 lymphocytes, from PCR-positive per-
sons was tested using the AmpliTaq Gold system
(Applied Biosystems/Roche, Branchtown, New Jersey)
on a BioRad CFX96 iCycler (Hercules, CA) for 95°C for
10 min, followed by 55 cycles of 95°C and 52°C for 15
sec each, and 62°C for 30 sec. Standard control tem-
plates were engineered from pol sequences from SFV-
infected humans, NHPs, or cell lines with primers SIF3
and SIR3 [26] or DNHP2N (5’CCTTTTGATAAATTYT
WATTGAYTATATTGG3’) and FVPGR2 (5’CCCTTTG
CAAACCCCGATACACTTGACTTC3’) and cloned into
pCR2.1 TOPO (Invitrogen, Carlsbad, CA). To ensure
broad reactivity of the assay for detecting monkey and ape
SFVs, control templates were generated from known SFV-
positive persons from Cameroon (2719YI, 1465MV,
1083MO, and 2467LE) infected with SFV variants from
mona monkey (Ce. mona), mandrill (Mandrillus sphinx),
gorilla (Gorilla gorilla), and greater spot-nosed monkey
(Ce. nictitans) [25], respectively, a worker (199917) and
chimpanzee (X174) infected with chimpanzee SFV
(SFVcpz) [33], and cell lines infected with macaque
(SFVmac), orangutan (SFV11), baboon (SFV10), or Afri-
can green monkey (SFV3) SFVs.Statistical methods
All collected information for the study population of
3,846 persons was used in estimation of SFV prevalence,
frequency and percentage with exposure to NHPs, and
assessment of epidemiological associations with SFV in-
fection. Non-monotonically missing data included 512
(13.3%) persons with missing plasma for serological test-
ing data, 850 (22.1%) missing exposure survey data, and
106 (2.8%) missing demographic data. The data were
assumed to be missing at random for implementation of
multiple imputation methods [45]. All variables used inthe analyses, in addition to auxiliary variables that may
be associated with variables having missing data, were
included in the multivariate normal imputation model as
binary-coded variables. A MCMC method of multiple
imputation replaced each missing value with a set of
plausible values that represent the uncertainty about the
unknown values. Diagnostic tests were performed to
examine stability and convergence. Ten complete data
sets were then analyzed using standard procedures and
the results were combined from these analyses. Results
from multiply imputed complete datasets were com-
pared to those estimated from incomplete data to dem-
onstrate close reproduction of relationships in the data
(data not shown).
Variables indicating exposure to various NHP species
or activity (e.g. hunting, cooking, etc.) that led to expos-
ure were created by combining binary responses to pri-
mate exposure-specific survey questions (e.g. hunting
Co. angolensis, cooking Co. angolensis, etc.). Created
NHP exposure variables are binary; exposure activity
variables are discrete, summing the number of different
species that were encountered for a specific activity. Be-
cause these two types of exposure variables (NHP spe-
cies and activity) were created from the same survey
questions, multicollinearity exists between these vari-
ables. For this reason, two distinct multivariable regres-
sion models were implemented to assess factors
associated with SFV infection, one that included vari-
ables for exposure to NHP species, the other including
NHP exposure activities. The NHP exposure activity
variables were further refined to reflect results from the
model of SFV risk associated with NHP species. Of the
ten NHP species or species groups, the five with the
greatest SFV prevalence were equally weighted to that of
the other five lower prevalence species groups combined;
the discrete exposure activity variables therefore have
possible outcomes ranging from 0 to 6. Multivariable
and single variable logistic regression models of SFV
prevalence were implemented to assess association with
the demographic variables age and gender, daily visits to
the forest, and NHP exposure related activities or expos-
ure to species. Odds ratios and 95% confidence limits
were calculated.
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